p.dom-wt1-37 dna vaccine and p.dom-wt1-126 dna vaccine
Biologicalexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2010 (NCT01334060)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Wilms tumor proteinImmunity, active
immunity, active - wt1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p.dom-wt1-37 dna vaccine and p.dom-wt1-126 dna vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01334060 | Phase 2 | Feb 1, 2010 | Inovio Pharmaceuticals, Leukemia Research Foundation, Moorgreen Hospital, Southampton, University of Exeter, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2010 |
| Leukemia Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Moorgreen Hospital, Southampton | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Exeter | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
5 organizations
Page 1 / 1